←
Common Sense Oncology673 posts
Common Sense Oncology avatar

Common Sense Oncology

@csoncol
◷ Joined April 2023▧ 165 Photos and videos
Common Sense Oncology avatar
Common Sense Oncology@csoncol·Nov 17

Junte-se a nós online para discussões com base em Common Sense Oncology sobre o estudo clínico com daraxonrasib para câncer de pâncreas e sobre o uso de apalutamida perioperatória em casos de câncer de próstata localizado e de alto risco. Sexta-feira, 27 de novembro, 16h (UTC-3:00) Cadastre-se aqui: tinyurl.com/6rfkpbck #CommonSenseOncology #CancerCare (Note: This webinar will be conducted in Portuguese.)

Post attachment
Common Sense Oncology avatar
⟳ Common Sense Oncology retweeted
Common Sense Oncology@csoncol·Nov 9

Reminder to join CSO online on November 16th at 2 pm (EST) for a critical appraisal of the RASolute 302 trial, followed by a discussion of how the pricing of daraxonrasib will impact patient access. Register now: tinyurl.com/bdfxy27a #CommonSenseOncology #CancerCare

Join CSO on November 16th for a critical appraisal of the RASolute 302 trial, followed by a discussion of how the pricing of daraxonrasib will impact patient access. Where: Online (Zoom) When: Monday, November 16, 2026 at 2:00 pm (EST) / 1:00 pm (CST) / 12:00 pm (MST) Speakers: Dr. Ian Tannock, Dr. Chris Booth, Dr. Sharlene Gill, Carolyn Taylor, Dr. Ramy Sedhom Register now: tinyurl.com/hr3jsnxc #CommonSenseOncology #CancerCare #Daraxonrasib

Post attachment
Common Sense Oncology avatar
Common Sense Oncology@csoncol·Nov 10

In this episode of the Common Sense Oncology podcast, doctors @drbrookewilson, Chris Booth, @hafaydeefe, and patient advocate Carolyn Taylor discuss the new breakthrough pancreatic cancer drug Daraxonrasib, and what its price tag of $40,000 USD per month, or $56,300 CAD per month, means for patients in North America and across the globe. Listen on your favourite platform: Spotify: open.spotify.com/episode/0YG… Apple: podcasts.apple.com/us/podcas… #CommonSenseOncology #CancerCare #Daraxonrasib

Post attachment
Common Sense Oncology avatar
Common Sense Oncology@csoncol·Nov 6

Cancer trials increasingly measure quality of life. But are we asking—and answering—the questions patients really need answered? What are the chances a treatment will make me feel better or worse? How will it affect my ability to function? How long might those effects last? And how do we weigh quality of life against the potential benefits of treatment? Join Drs. Madeline Pe, Ian Tannock, and Michael Brundage on November 13 at 11 a.m. ET for a high-level conversation about making quality-of-life evidence more meaningful for patients, followed by an extended panel discussion and Q&A. Register here: us02web.zoom.us/webinar/regi… #CommonSenseOncology #CancerCare @MichelleTregear

Post attachment
Common Sense Oncology avatar
Common Sense Oncology@csoncol·Nov 5

Join CSO on November 16th for a critical appraisal of the RASolute 302 trial, followed by a discussion of how the pricing of daraxonrasib will impact patient access. Where: Online (Zoom) When: Monday, November 16, 2026 at 2:00 pm (EST) / 1:00 pm (CST) / 12:00 pm (MST) Speakers: Dr. Ian Tannock, Dr. Chris Booth, Dr. Sharlene Gill, Carolyn Taylor, Dr. Ramy Sedhom Register now: tinyurl.com/hr3jsnxc #CommonSenseOncology #CancerCare #Daraxonrasib

Post attachment
Common Sense Oncology avatar
Common Sense Oncology@csoncol·Nov 2

CSO and oncologists across Canada are speaking out about escalating cancer drug costs after the recent U.S. pricing announcement for the new pancreatic cancer drug daraxonrasib. The list price of CAD$56,300 per month means it will be inaccessible to many patients and health systems, and risks turning a breakthrough treatment into an unfulfilled promise to cancer patients. Watch the segment on daraxonrasib from CBC's The National for more: tinyurl.com/aaecm4nv #CommonSenseOncology #CancerCare

Common Sense Oncology avatar
Common Sense Oncology@csoncol·Nov 2

Join CSO this Thursday, November 5th online for London Global Cancer Week! Register here: tinyurl.com/5n7m9be8 #CommonSenseOncology #CancerCare

This is your reminder to catch up with CSO during London Global Cancer Week! This online session will review progress to date on CSO’s major outputs, work-in-progress, and highlight ways that oncologists, advocates, organisations, and people with lived experience can engage with the CSO initiative. Where: Online (Zoom) When: Thursday, November 5, 2026 - 18:30 - 20:00 (GMT) | 1:30 pm - 3:00 pm (EST) Speakers: Dr. Christopher Jackson, Dr. Ian Tannock, Dr. Manju Sengar, Dr. Haydeé Verduzco, Dr. Michelle Tregear RSVP at the following link: tinyurl.com/js5hbeaz #CommonSenseOncology #CancerCare

Post attachment
Common Sense Oncology avatar
Common Sense Oncology@csoncol·Oct 27

The development of innovative new cancer medicines that meaningfully improve patient survival and quality of life is to be celebrated. But a new commentary from Common Sense Oncology published in The Lancet Oncology warns that spiraling prices risk turning these new treatments into unfulfilled promises, because they may not be accessible to the patients who need them. Read more on our website: commonsenseoncology.org/blog… #CommonSenseOncology #CancerCare

Post attachment
Common Sense Oncology avatar
Common Sense Oncology@csoncol·Oct 26

Thank you for making the Common Sense Oncology event at ESMO in Madrid a success this past Friday! It was a great opportunity for oncologists from around the world to connect over a shared interest in outcomes that matter for cancer patients and health care systems. We look forward to seeing you again at our next event! #CommonSenseOncology #CancerCare

Post attachment
Common Sense Oncology avatar
Common Sense Oncology@csoncol·Oct 20

This is your reminder to catch up with CSO during London Global Cancer Week! This online session will review progress to date on CSO’s major outputs, work-in-progress, and highlight ways that oncologists, advocates, organisations, and people with lived experience can engage with the CSO initiative. Where: Online (Zoom) When: Thursday, November 5, 2026 - 18:30 - 20:00 (GMT) | 1:30 pm - 3:00 pm (EST) Speakers: Dr. Christopher Jackson, Dr. Ian Tannock, Dr. Manju Sengar, Dr. Haydeé Verduzco, Dr. Michelle Tregear RSVP at the following link: tinyurl.com/js5hbeaz #CommonSenseOncology #CancerCare

Post attachment
Common Sense Oncology avatar
Common Sense Oncology@csoncol·Oct 20

The CSO Symposium at ESMO is happening this Friday, October 23rd! RSVP here: forms.gle/ETTmXfLavnSwh2by5 #CommonSenseOncology #CancerCare

🚨 CSO at ESMO 2026 is 9 days away! This is your reminder to attend and hear updates on the movement and regional developments across the globe. Network with likeminded individuals and enjoy light refreshments. Speakers will give short talks about CSO-aligned activities in their respective countries. There will be time for attendees to ask questions and talk about what’s happening in their own systems. Where: ESMO venue, IFEMA, Madrid, Spain - Room A6.1 When: Friday, October 23, 2026 - 18:00 - 19:30 Speakers: Dr. Winette van der Graaf, Dr. Dario Trapani, Dr. Chris Booth, Dr. Rodrigo Lastra del Prado, Dr. Francesco Perrone, Dr. Jolien Tol, Antonella Cardone Planning to attend? RSVP here to let us know! (RSVP is NOT mandatory to attend.) forms.gle/fxfDXnN9xAj3QseR9 #CancerCare #CommonSenseOncology

Post attachment